Erick Co | Chief Scientific Officer
Formosa Pharmaceuticals | Taiwan

Erick Co, Chief Scientific Officer, Formosa Pharmaceuticals

Dr. Co earned his B.S. degree in Chemistry from the California Institute of Technology and a Ph.D. in Synthetic Organic Chemistry from UCLA, specializing in natural products total synthesis.  Trained as a medicinal chemist in leading biotech and pharma companies such as Exelixis and Takeda, where he contributed to several clinical phase candidates, Erick transitioned into managerial roles at Nitto Denko and ScinoPharm Taiwan.  He currently serves as Chief Scientific Officer for Formosa Pharmaceuticals and its wholly-owned subsidiary, Activus Pharmaceuticals, in Japan.


Phar-East Day One @ 16:20

Biotech Showcase- Activus Pure Nanoparticle Technology (APNT) Platform

Formosa Pharmaceuticals will present the Activus Pure Nanoparticle Technology (APNT) platform, which improves the physicochemical properties (solubility, absorption, bioavailability) of poorly-soluble APIs.  APNT efficiently reduces particle size without the drawbacks of other conventional milling processes, including heavy metal contamination.

back to speakers